tissue-specific transcriptional dysregulation of the core genes in two independent RNA-seq 168 are the distance a mutation signal is allowed to travel through the network (termed diffusion 169 length α from now on), and the percentage of top edges to be retained in the network in a 170 procedure called binarisation. We generated synthetic datasets, varying parameters of 171 mutation frequency in cases and controls, and applied network propagation using varying 172 parameter settings of the algorithm. In these simulations we focus on an un-mutated target 173 gene and vary the mutation frequency in the gene's neighborhood differentially between cases 174 and controls. Next, we test how well the smoothed score obtained through network 175 propagation in the target gene separates cases from controls. Further details can be found in 176 SI Appendix. A summary of results from the investigation of the parameter space for network 177 propagation on simulated data can be found in Figure 2 and Supplementary Figure 1 . We 178 observed (Supplementary Figure 1B) that variation in both diffusion length α and percentage 179 of edges retained influences the difference in a hub gene's smoothed score between cases 180 and controls only marginally. Therefore we adopted a parsimonious approach and selected 181 as default parameters for real data applications a mid-range α value of 0.5 and a top edge 182 percentage of 1%. As expected, for α=0 no propagation occurs. We also observed 183 (Supplementary Figure 1A) a detrimental effect on the smoothed scores (loss of statistical 184 significance) when quantile-normalisation, which is used in Hofree et al. [19] , is applied at the 185 end of network propagation, therefore we decided to exclude this step from our pipeline. Small sample: ADNI. We used NETPAGE in ADNI to test smoothed scores for M = 13,310 207 genes for association with binary disease outcome in N = 439 Caucasian subjects (222 healthy 208 controls [HC], 217 AD). One gene resulted from stability selection on the smoothed scores in 209 ADNI ( Figure 3A) : PFAS (selection probability = 0.85; Table 2 ). We replicated the selection of 210 PFAS when testing the gene burden propagated through the STRING network (selection 211 probability = 0.85; Supplementary Figure 2 ). No genes were selected when running stability 212 selection on the "raw" mutation profile (α = 0, no smoothing), nor when the mutation profile 213 was smoothed through either a randomised version of the hippocampus network or a non-214 brain-related network (umbilical cord; Supplementary Figure 3 ).
215
When a burden including only rare deleterious stop-gain, stop-loss and frameshift mutations 216 was smoothed (through either the hippocampus or the STRING PPI network) and tested for 217 association with diagnosis, no genes were selected ( Supplementary Figure 4 ).
219
Medium sample: ADSP. We used NETPAGE in ADSP to test smoothed scores for M = 16,298 220 genes for association with binary disease outcome in N = 10,186 Caucasian subjects (4601 221 HC, 5585 AD). Stability selection on the smoothed scores in ADSP identified 29 genes as 222 robust predictors of case-control status ( Figure 3B ). Selection probabilities for these 29 genes 223 are reported in Table 2 . As an example, figure 3C shows the subgraph of radius two centred 224 on CAMK2B, including interesting second neighbours of relevance to AD dementia or other 225 neurodegenerative disorders. Eighteen genes selected from ADSP were found to be second 226 neighbours of the gene selected from ADNI (PFAS) in the hippocampus network. This number 227 is significantly higher than it would be expected by chance (p < 10 -4 ; Supplementary 
262
4A; mass univariate smoothed, Supplementary Figure 4B ). 288 education, population structure; chi-squared test p = 2x10 -4 ). Additionally, the extended model 289 showed a higher pseudo-R 2 statistic (p-R 2 = 0.36) than the baseline model (p-R 2 = 0.33),
290
approximately equivalent to an additional 3% variance explained in the outcome.
15
In ADSP, we found that CSNK1A1 was a second neighbour of PFAS, had a selection 292 probability of 1 and provided the best improvement in goodness-of-fit to case-control status 293 over the baseline model including sex, age and APOE ε4 (chi-squared test corrected p = 1x10 -294 36 ; Table 2 ).
296
Survival analysis. We postulated that the smoothed scores possess unique properties in that 297 they condense in a biologically meaningful way information on how mutations in a 298 neighbourhood interact, acquiring an increased sensitivity to disease phenotypes. We 299 therefore set out to further characterise the properties of such scores by assessing their 300 relationship not only to simple case-control status but also to risk of clinical disease 301 progression to AD.
302
The "raw" (binary) mutation status and smoothed score for PFAS in ADNI were tested 303 for association with risk of conversion to AD using Cox proportional hazards model. The binary 304 mutation status of PFAS was not seen to influence the probability of conversion to AD (p = 
343
In the Mayo RNA-seq dataset, none of the investigated genes showed significant 344 dysregulation between controls and AD cases after correction for cell type gene markers. Full 345 results and visualisations of the differential expression analysis in the Mount Sinai dataset for 346 parahippocampal gyrus are reported in Supplementary Table 4 and Supplementary Figure 10 .
347
We observed a trend towards downregulation for PFAS and SHOC2 in controls vs definite AD
348
(pPFAS = 0.04; pSHOC2 = 0.001); however these did not survive multiple comparisons correction.
349
Sixteen genes among the 30 analysed were found to be differentially expressed in at least 350 one pairwise comparison of disease severity. A randomisation control demonstrated that this 351 number is significantly higher than it would be expected by chance (p < 0.001; Supplementary 352 Figure 11 ). In particular, significant dysregulation in controls vs definite AD was observed for
354
MOB4, and TREM2.
355

DISCUSSION 356
In this work we presented NETPAGE, a computational tool for gene-based association testing 357 of rare variants that integrates prior knowledge about tissue-specific gene interaction 358 networks. The aim was to boost the information content assigned to each gene, by enriching 359 it with the knowledge of the pathways through which rare variation percolates. NETPAGE 360 leverages the well-known strength of network propagation, combining it with multivariate 361 sparse regression to identify genes robustly associated with a disease phenotype by analysing 362 the genome-wide landscape as a whole and without the need for stringent statistical 363 corrections.
364
NETPAGE allowed us to reveal correlations between the propagation of rare variant 365 effects at the gene level and disease outcomes (both diagnosis and risk of conversion), as 366 well as tissue-specific downstream effects of such propagation at the transcriptomic level. We 367 tested the proposed method on a small dataset (ADNI), as well as on a medium-sized sample 368 (ADSP). This enabled us to put the spotlight on a set of genes mutually connected in the 369 hippocampus network and belonging to the same neighbourhood of diameter two. We were 370 also able to demonstrate robustness to the choice of network by replicating the association 371 with PFAS with the STRING PPI network. But one of the core features of NETPAGE is its 372 flexibility and applicability to a wide range of traits and diseases whose genetic architecture 373 follows the trend described by Manolio et al. [2] .
374
We investigated the behaviour of the network propagation step in NETPAGE through 375 simulated data for a range of mutation frequencies, and optimised some of the key parameters 376 of the diffusion process. As expected, when the neighbouring genes' mutation frequencies do 377 not differ between cases and controls, no difference is detectable in the smoothed score of 378 the hub gene, whereas different mutation frequencies in the neighbouring genes always flow 379 into the hub to determine a smoothed score significantly different between cases and controls, 380 even when the hub gene itself is not mutated, under a range of parameters and mutation 381 scenarios. In agreement with Hofree et al [19] , we also found the diffusion length α to have a 382 minor, if not negligible, effect on the hub gene's smoothed score over a sizable range and in 383 19 all mutation scenarios considered. However, in contrast to Hofree et al., we found the final 384 quantile normalisation step to be detrimental to the process and therefore excluded it from our 385 applications to real data.
386
Since we regard NETPAGE as a gene-based association testing tool, we compared its 387 performance against SKAT, a state-of-the-art method for gene-and set-based association 388 testing of rare variants, in both datasets. In contrast to Bis et al. [11] , SKAT-O on ADSP did 389 not identify any significant gene, which may be due to difference in SNV inclusion criteria. 
396
[30], or NBS [19] . However, benchmarking NETPAGE against these methods is not a 397 straightforward task, since these methods were designed for purposes fundamentally different 398 from association testing, namely gene prioritisation, module detection, or patient stratification, 399 respectively.
400
We also investigated the effect of different selection criteria to include SNVs in the 401 mutation burdens to be propagated through the network. When we focused on stop-gain, stop-402 loss and frameshift insertions to derive our gene burdens for network propagation, we did not 403 detect any association signal. This type of mutations has generally a higher functional impact 404 than missense mutations, and is therefore usually subject to stronger selective pressure due 405 to a dramatic decrease in fitness. This translates into even sparser mutation profiles, whereby 406 the "signal enhancement" capability of network propagation is still not sufficient to reveal 407 separation between cases and controls. We conclude that the inclusion criteria for SNVs -408 which are not to be regarded as a parameter of the algorithm underlying NETPAGE but rather 
415
Ontology annotations for PFAS include the term 'glutamine metabolic process' (GO:0006541).
416
The metabolism of glutamine and the glutamine-glutamate cycle takes place in the brain at 
431
We demonstrated the successful application of NETPAGE to two independent datasets, 432 one of small sample size (ADNI) and the other of moderate sample size (ADSP). In conducting 433 these experiments, we did not seek to achieve replication of the selected genes; this task is 434 an intrinsically challenging one, given the rarity of the mutations considered, the difference in 435 coverage (an additional 3,000 genes were tested in ADSP that were not present in ADNI), and 436 the small sample considered in ADNI. Our main focus was to demonstrate the validity of the 437 proposed method in application to two very different, real-world experimental scenarios.
438
However, it is indeed remarkable that short-range functional connections link a subset of the genes selected in the two datasets in a statistically significant fashion ( Supplementary Figure   440 5), and we believe this to be a powerful proof of the working hypothesis underlying NETPAGE.
441
The role of PFAS as hub of a molecular pathway disrupted in AD is further strengthened 442 by the finding of extensive and significant overlaps between the subnetwork centred on PFAS 443 and the KEGG AD pathway, as well as with curated sets of genes affected by transcriptional 444 dysregulation at distinct stages of the disease ( Supplementary Table 3 and Supplementary 445 Figure 9 ). Additionally, the interactome of PFAS appears to be enriched in genes related to a 446 number of key ontology terms ( Supplementary Figure 8) , among which: biological processes 447 such as cell ageing, microtubule-based processes, and mRNA metabolism; and cellular 448 components such as mitochondria, myelin sheath, axon cytoplasm, and ribonucleoprotein 449 complexes [46] . These overlaps provide additional support to the hypothesis that rare 450 deleterious variation percolates through the network structure to significantly alter the protein 451 landscape of the cellular environment in a pathological way. However, we also showed that 452 these alterations are tissue-specific (and most likely even cell type-specific), since we reported 453 differential expression for some of the core genes identified in the parahippocampal gyrus 454 from the Mount Sinai dataset but not in samples from the broader temporal cortex in the Mayo
455
RNA-seq dataset, at different disease stages ( Supplementary Table 4 ). More importantly, we 456 observed transcriptional alterations in relation to AD diagnosis in more than half of the putative 457 core genes investigated, and demonstrated that this effect could not have been observed by 458 chance (Supplementary Figure 11) . This finding can be interpreted as pointing towards a co-459 expression module altered by disease. This further supports our idea that integrating 460 information about variation and interactions is a powerful approach to gain a comprehensive, 461 systems-level view of disease-related molecular mechanisms, as opposed to the investigation 462 of single variants or genes of interest. However, as we did not detect differential expression 463 for all the genes identified, we speculate that the link between these putative core genes and 
468
We proposed NETPAGE, a methodology that enables the exploration of biological 469 pathways through which structural variation affects tissue function and results in complex 470 disease phenotypes. The rationale followed by NETPAGE resembles aspects of the recently 471 proposed, although debated, omnigenic model [14, 47] . There remain, however, some 472 limitations. First, an inherent difficulty is that the ADNI dataset is a low-coverage WGS, while 473 ADSP is WES, which can be biased due to the required exome enrichment step. Therefore, 474 on one hand ADNI might not provide a very clean signal, while on the other hand ADSP might 475 not enable a strict validation due to the different sequencing methods utilised. Second, we 476 restricted this initial study design to include only rare exonic SNVs whose deleteriousness was 477 assessed through the CADD score. Extensions of this work may address the impact on gene 
485
In summary, we demonstrated a novel application of network propagation to the study of rare 486 variant effects on complex traits in two sporadic, late-onset AD cohorts. NETPAGE allowed 487 us to identify a set of genes as tightly interconnected network hubs where the downstream 488 influence of rare mutation accumulates and acquires predictive power for diagnosis, as well 489 as to provide multiple lines of evidence for the biological meaning of the smoothed scores and 490 the tissue-specific involvement of some core genes at the transcriptional level. We emphasise 491 the flexibility of the presented methodology, that enables enhanced association testing for 492 binary and continuous traits, as well as small and large sample sizes, as NGS is becoming an 493 increasingly affordable alternative to SNP genotyping and adopted in many cohort and 494 23 biobank studies. We believe NETPAGE is a promising approach for determining novel genetic 495 influences on complex traits and for providing mechanistic insights into disease biology. Table 1 . 511 512 ADSP WES data preprocessing. The ADSP WES dataset (N=10,913) was then used for 513 application to a moderate sample size. We identified 24 samples who were also sequenced 514 as part of ADNI, who were then removed from the ADSP WES dataset, yielding a sample size 515 of 10,889 (SI Appendix). Demographics and clinical outcomes for this final sample are 516 presented in Table 1 . 
518
539
To assess the impact of the filtering criteria outlined above we constructed a second set of 540 SNVs, by retaining exonic variants with MAF < 1% predicted to have a stop-gain, stop-loss or 541 frameshift consequence. We also applied the CADD phred > 20 filter to stop-gain and stop-542 loss variants.
543
Exonic SNVs were mapped to genes according to annotations based on the RefSeq database 544 [53] . These filtering and mapping procedures were applied to the ADNI and ADSP datasets 545 separately.
547
Tissue-specific gene interaction networks. As a substrate for network propagation, we 548 leveraged tissue-specific weighted gene interaction networks from Greene et al. [15] . In these 549 networks, each node represents a gene, each edge a functional relationship, and an edge 550 between two genes is probabilistically weighted based on experimental evidence connecting 551 both genes. We focused on the interaction network for the human hippocampus, being the 552 key brain structure related to the loss of episodic memory in AD [54] . Additional negative 553 controls were performed using: a randomised version of the same hippocampus network, 554 obtained by shuffling edges after binarisation (see next section); and a gene network not 555 related to brain tissue, specifically the umbilical cord network.
556
Lastly, we investigated the robustness of the method with respect to the network structure by 557 using the human, non-tissue-specific protein-protein interaction network (PPI) available 558 through the STRING database [21] .
560
Propagation of mutation signals through gene interaction networks. To model the 561 propagation of the effects of rare mutations through a gene interaction network, we adopted 562 the network propagation approach first introduced by [55] for semi-supervised learning. In our 563 case, a gene carrying a deleterious variant is used as a seed in an iterative procedure that 564 propagates its effect according to the network structure. Hence the effect propagation 565 effectively reproduces a graph-constrained diffusion process whereby information from the 566 seed gene flows not only to its first neighbours but to all genes in a connected component, 
579
where 561 is the smoothed mutation profile at iteration + 1; ∈ [0,1] is a tuning parameter 580 governing the distance a signal is allowed to diffuse through the network, and ∈ ℝ -×is a 581 diagonal matrix with the inverse of the node strengths of N along the diagonal. Equation (1) is 582 iteratively evaluated until convergence (i.e., until the L 2 -norm of 561 − 5 is smaller than a 583 pre-specified threshold).
584
Our implementation of network propagation in NETPAGE allows the user to specify: 585 whether the network used is a gene-or a protein-interaction network, and the gene/protein 586 naming convention; the type of encoding used in the input file (i.e., if rare-variant burden or 587 rare-variant status is used); the convergence threshold on ‖ 561 − 5 ‖ 2 (default 10 -6 ); the 588 diffusion length α (default 0.5); this was optimized through simulation; whether the full 589 28 weighted graph is to be used to guide the diffusion process, or if a graph adjacency matrix is 590 to be generated from the original graph by retaining only the top P% edges (we refer to this 591 procedure as network binarisation); the percentage P of top edges to be retained, in case 592 network binarisation is to be performed (default 1%); this was optimized through simulation; 593 whether the gene interaction network features self-loops (default False); whether the rows of 594 the smoothed mutation profile are to be quantile-normalised after convergence (default False).
595
Quantile normalisation is the last step performed after network propagation by NBS [19] , to 596 ensure that the smoothed mutation profile for each patient follows the same distribution.
597
Network propagation is sensitive to the direction of the mutation's effect (i.e., protective 598 vs. deleterious), therefore the user can choose if and how to deal with the direction of effects 599 of the genes' mutational burdens with respect to a given binary phenotype. Briefly, the 600 bioinformatics assessment of deleteriousness (e.g., CADD score) is unrelated to any disease 601 phenotype, hence the mutational status of a given gene can be equally risk-increasing or 602 protective with respect to a specific binary phenotype, resulting in blended effects in signal-603 receiving genes. Therefore, we require a mechanism to numerically distinguish the "signal" 604 flowing into a hub from a protective gene from the "signal" coming from a risk gene. In light of 605 this, we are providing the user with additional flexibility to either: set to 0 the mutation 606 status/burden of protective genes; set to 0 the mutation status/burden of risk genes; set the 607 mutation status to -1 for protective genes and to +1 for risk genes; none of the above. Risk 608 and protective genes are determined by the direction of effect of their mutation status on the 609 case-control status (odds ratio from a Fisher's test on the 2x2 contingency table). 610 611 NETPAGE: application to AD sequencing data. We performed network propagation on the 612 full (i.e., without filtering on ancestry or diagnosis) ADNI and ADSP datasets separately. Each 613 subject-level mutational burden (row of the 0 matrix) was encoded as a binary vector of length 614 M (0 = gene not carrying any of the selected SNVs, 1 = gene carrying at least one of the 615 selected SNVs). The 0 matrix in ADNI described the mutation status of 13,310 genes for 808 616 29 study participants. The 0 matrix in ADSP described the mutation status of 16,268 genes for 617 10,889 study participants. In both applications, we used the default values for the parameters 618 α and P, as optimised through simulations, and set the mutation status to -1 for protective 619 genes and to +1 for risk genes. 
625
Briefly, glmnet finds the coefficients' vector β that solves the following regularised regression 
